Therefore, there are less likely chances of latent IFNα2b developed in the present study to be activated in the serum of CHC patients until reached at the target site (liver) and activated by NS3 protease present at the surface of HCV infected cells. Here, IFNA2 is linked to cryohydrocytosis.